Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa Workshop Summary (2014) / Chapter Skim
Currently Skimming:
Appendix C: Workshop Agenda
Appendix C: Workshop Agenda
Pages 115-126
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 115... ...
Efforts in this area should not try to complete for resources used to combat infectious diseases, but should, instead, try to leverage those ongoing activities with initiatives targeted to MNS disorders. For low- and middle-income countries improving access to essential medicines can be a tremendous challenge and a critical barrier to scaling-up care for MNS disorders.
|
From page 116... ...
o Explore challenges and opportunities for improving access to essential medicines in four critical areas: demand, selection, supply chains, and financing and pricing • Examine successful activities that increase access to essential medicines both within SSA and in other developing countries. o Identify critical components of these models that might be features in SSA programs focused on MNS disorders.
|
From page 117... ...
Exploring successful access to medicine frameworks HANS HOGERZEIL Professor of Global Health Groningen University 9:40 a.m. Charge to participants: workshop objectives and deliverables TEDLA GIORGIS Advisor, Officer of the Minister Ministry of Health, Ethiopia SESSION I: CHALLENGES AND OPPORTUNITIES FOR IMPROVING ACCESS TO ESSENTIAL MEDICINES Session Objectives: Explore feasible opportunities for improving access to essential medicines in four challenge areas: de mand, selection, supply chains, and financing/ pricing.
|
From page 118... ...
Challenge 1: Insufficient Demand How is patient demand adversely affected by: • The prevailing standard of care for MNS disorders? • Provider training, prescribing ability, and prescribing knowledge?
|
From page 119... ...
PRASHANT YADAV Director, Healthcare Research William Davidson Institute University of Michigan 11:30 a.m. Challenge 4: High Pricing/Poor Financing How are pricing and financing of medicines adversely affected by: • Tariffs and taxes placed on supply prices?
|
From page 120... ...
For example, would increases in demand positive ly boost willingness of groups to finance essential medicines for MNS disorders? DAVID MICHELSON, Session Chair Vice President, Clinical Neuroscience and Ophthalmology Merck Research Laboratories 1:10 p.m.
|
From page 121... ...
, Tanzania 3:00 p.m. Set Two -- Infectious Disease Programs Example III -- MDR-TB PAUL ZINTL Senior Advisor for Planning and Finance Program in Infectious Disease and Social Change Harvard Medical School 3:20 p.m.
|
From page 122... ...
WRAP-UP AND ADJOURN DAY TWO 8:15 a.m. Day Two Welcome STEVEN HYMAN, Chair Director Stanley Center for Psychiatric Research The Broad Institute
|
From page 123... ...
8:50 a.m. Session Objectives and Goals FRANCES JENSEN, Session Chair Professor and Chair, Department of Neurology University of Pennsylvania Health System
|
From page 124... ...
Discuss barriers and opportunities at the level of country income and MNS disorder. Challenge Area 1: Demand PAMELA COLLINS, Challenge Facilitator Challenge Area 2: Selection ATUL PANDE, Challenge Facilitator Challenge Area 3: Supply Chains TEDLA GIORGIS, Challenge Facilitator Challenge Area 4: Pricing/Financing DAN CHISHOLM, Challenge Facilitator 12:30 p.m.
|
From page 125... ...
3:45 p.m. Overview STEVEN HYMAN, Chair Director Stanley Center for Psychiatric Research The Broad Institute 3:50 p.m.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.